Introduction: Patients with advanced hepatocellular carcinoma (HCC) face an extremely poor prognosis. Sorafenib, a multikinase inhibitor, remains an essential treatment for advanced HCC in certain cli

DataCite Commons2025-05-22 更新90

Supplementary Material for: The impact of radiation dose and tumour burden on outcomes in hepatocellular carcinoma: 11-year experience in a 413-patient cohort treated with yttrium-90 resin microsphere radioembolisation

肝细胞癌

放射栓塞术

Introduction Transarterial radioembolisation (RE) using yttrium-90 (Y-90) microspheres is a widely used locoregional therapy for a broad spectrum of HCC given its favourable safety profile. We evaluat

DataCite Commons2024-11-06 更新30

Supplementary Material for: Loss of DAXX/ATRX protein expression results in ischemia resistance and radiation sensitivity in pancreatic neuroendocrine tumor cells and is associated with improved response to trans-arterial radio-embolization

胰腺神经内分泌肿瘤

放射栓塞术

ntroduction: Metastatic liver pancreatic neuroendocrine tumors (PNETs) can be treated with ischemia-based (trans-arterial embolization [TAE]/trans-arterial chemo-embolization [TACE]) or radiation-base

DataCite Commons2025-07-22 更新90

Additional file 1: Figure S10. of Clinical and imaging-based prognostic factors in radioembolisation of liver metastases from colorectal cancer: a retrospective exploratory analysis

放射栓塞术

结直肠癌肝转移风险

Case studies representing each of the scenarios discussed in the manuscript with regards to lesional dose–response: high average dose (>50 Gy) achieving a CMR (a); intermediate average dose (20–50

DataCite Commons2024-12-18 更新40

Radioembolization treatment characteristics.

资源简介：

相关数据集